Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001209191-23-016932

Options or other derivatives

  • Co-CEO acquired 733,944 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Patel Chintu Co-CEO 2023-03-03 Grant or award · Performance-Based Restricted Stock Units +733,944 733,944 D
Loading xslF345X03/doc4.xml…